EZH2 and nasopharyngeal carcinoma: Li et al. 87 found that H19 suppressed E-cadherin expression and promoted NPC cell invasion by regulating the miR-630/EZH2 pathway, which suggested a possible therapy for NPC (Fig. 2A).